chronic pancreatitis

in review 3 min read Updated 2026-10-28
chronic pancreatitis

Progressive fibrosis → pain, exocrine insufficiency (steatorrhoea, weight loss), diabetes. Diagnose with CT or MRI (calcifications, duct dilatation, atrophy); EUS or secretin-MRCP only if imaging is equivocal. Find the cause (TIGAR-O; genetics if young or unexplained). Stop alcohol and smoking. PERT treats malabsorption, not pain. Pain: non-opioid analgesia → endoscopic drainage of obstructed ducts → surgery if that fails. Autoimmune pancreatitis mimics cancer and responds to steroids.

diagnosis

  • CT or MRI first; EUS (invasive, non-specific) only if cross-sectional imaging is equivocal. Secretin-enhanced MRCP when suspicion stays high.
  • Histology is the gold standard but rarely needed.
  • Pancreatic function tests (faecal elastase) diagnose exocrine insufficiency, not chronic pancreatitis itself.
  • Lipase is often normal — burnt-out gland.

aetiology (TIGAR-O)

examples
Toxic-metabolicalcohol, smoking (independent, synergistic), hypercalcaemia, hypertriglyceridaemia, CKD
Idiopathicearly and late onset
GeneticPRSS1, SPINK1, CFTR, CTRC → test if young or unexplained
Autoimmunetype 1 (IgG4-related) and type 2 AIP
Recurrent acuterecurrent acute pancreatitis progressing to fibrosis
Obstructivepancreas divisum, ampullary stenosis, tumour, post-necrotic stricture

Age >40 with new unexplained pancreatitis → exclude pancreatic cancer.

management

Remove the cause — alcohol and smoking cessation slow progression and reduce pain. Postpone elective procedures while drinking.

exocrine insufficiency

  • Steatorrhoea, weight loss, fat-soluble vitamin deficiency; faecal elastase low (<200 µg/g).
  • PERT with meals — e.g. ~40 000–50 000 lipase units with meals, half with snacks; add a PPI if response is poor.
  • Monitor nutrition: weight, vitamins A, D, E, K, and DEXA (osteoporosis common).

pain

  1. Analgesia (acetaminophen, NSAID, tramadol); opioids only after other options fail.
  2. Antioxidants: small benefit.
  3. PERT doesn’t relieve pain.
  4. Obstructed main duct (stones, stricture) → endoscopic therapy (ERCP ± lithotripsy).
  5. Endoscopy fails or pain recurs → surgery (drainage or resection) — better long-term pain relief than repeated endoscopy.
  6. Coeliac plexus block for selected patients; total pancreatectomy with islet autotransplantation only for highly selected refractory pain.

complications

  • Diabetes (type 3c) — loss of insulin and glucagon → brittle, hypoglycaemia-prone; screen periodically (HbA1c, fasting glucose).
  • Pseudocyst (vs cystic neoplasm → pancreatic cysts and familial pancreatic cancer surveillance), bile duct or duodenal stricture, splenic vein thrombosis (→ isolated gastric varices).
  • Pancreatic cancer risk is raised, but routine screening hasn’t shown benefit.

autoimmune pancreatitis

type 1type 2
diseasepancreatic part of IgG4-related diseaseduct-centric, granulocytic epithelial lesions
whoolder menyounger, either sex
serum IgG4often raisednormal
other organsbiliary (IgG4 cholangitis), salivary, kidney, retroperitoneumIBD (UC)
relapsecommon (~30%)rare (~10%)
  • Presents as painless obstructive jaundice, a “sausage-shaped” pancreas or a focal mass → pancreatic cancer must be excluded first (EUS-guided biopsy); a steroid trial is not a diagnostic shortcut unless cancer has been ruled out.
  • IgG4 cholangitis mimics PSC and cholangiocarcinoma → check IgG4 in sclerosing cholangitis (primary biliary and sclerosing cholangitis).
  • Serum IgG4 is the single best serological marker (>2× ULN strongly suggestive with jaundice or a mass), but normal in type 2.
  • Prednisone 0.6–1 mg/kg/day, reassess imaging and CA 19-9 at 2 weeks, taper over ~12 weeks total (not <4). Type 1 may need low-dose maintenance (2.5–7.5 mg/day up to 3 years) or a steroid-sparing agent; type 2 usually doesn’t. Mild jaundice without infection → steroids alone, stenting not required.
  • Steroids induce remission in almost all; rituximab if steroids are contraindicated or for relapse. Thiopurines alone don’t induce remission.
  • Treat symptomatic disease (jaundice, pain, other-organ involvement) or subclinical disease threatening irreversible damage.

Prepared 2026-10-28. Not yet verified — check every number against the sources.

Key references

+1 more source

Suggest a correction chronic pancreatitis